|
VPS13A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.83460000000069E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.590900E-04 |
| Normal-vs-Stage2 |
5.866200E-02 |
| Normal-vs-Stage3 |
8.429500E-04 |
| Normal-vs-Stage4 |
1.980240E-03 |
| Stage1-vs-Stage2 |
7.585200E-01 |
| Stage1-vs-Stage3 |
3.570600E-01 |
| Stage1-vs-Stage4 |
4.871600E-01 |
| Stage2-vs-Stage3 |
3.297800E-01 |
| Stage2-vs-Stage4 |
3.838200E-01 |
| Stage3-vs-Stage4 |
9.235800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.35739999999907E-05 |
| Normal-vs-AfricanAmerican |
5.016300E-03 |
| Normal-vs-Asian |
1.265880E-02 |
| Caucasian-vs-AfricanAmerican |
7.385800E-01 |
| Caucasian-vs-Asian |
6.821000E-01 |
| AfricanAmerican-vs-Asian |
6.556200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.93903999999856E-05 |
| Normal-vs-Female |
3.021900E-02 |
| Male-vs-Female |
6.777700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.858100E-03 |
| Normal-vs-Extreme_Weight |
4.19379999949676E-07 |
| Normal-vs-Obese |
1.547950E-02 |
| Normal-vs-Extreme_Obese |
1.500110E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.166800E-01 |
| Normal_Weight-vs-Obese |
3.147200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.670200E-01 |
| Extreme_Weight-vs-Obese |
1.748100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.122200E-01 |
| Obese-vs-Extreme_Obese |
6.504600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.392500E-02 |
| Normal-vs-Age(41-60Yrs) |
3.459500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.70869999996881E-07 |
| Normal-vs-Age(81-100Yrs) |
3.048200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.316600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.656200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.977200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.919990E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.062980E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.489200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.005500E-04 |
| Normal-VS-Type2 PRCC |
3.556800E-04 |
| Normal-VS-KIRP CIMP |
1.059640E-02 |
| Normal-VS-Unclassified PRCC |
4.963500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.293600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.441800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.313400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.985400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.816000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.196400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.397900E-04 |
| Normal-vs-N1 |
7.374000E-04 |
| Normal-vs-N2 |
1.493640E-02 |
| N0-vs-N1 |
7.181000E-01 |
| N0-vs-N2 |
6.721400E-01 |
| N1-vs-N2 |
7.874600E-01 |
|
|
